Stromelysin 1, neutrophil collagenase, and collagenase 3 do not play major roles in a model of chondrocyte mediated cartilage breakdown

Journal of Clinical Pathology - Molecular Pathology

Volumn 51, Issue 5, 1998, Pages 282-286

  Kozaci, L D ^a   Brown, C J ^a   Adcocks, C ^a   Galloway, A ^b   Hollander, A P ^a   Buttle, D J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b British Biotech Pharmaceuticals Ltd   (United Kingdom)

Author keywords

Arthritis; Cartilage breakdown; Metalloproteinase inhibitors; Metalloproteinases

Indexed keywords

BATIMASTAT; COLLAGENASE; GELATINASE A; LACTIC ACID; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; RECOMBINANT INTERLEUKIN 1; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; RETINOIC ACID; STROMELYSIN;

ARTICLE; CALORIMETRY; CARTILAGE CELL; COLLAGEN DEGRADATION; ENZYME INHIBITION; IMMUNOASSAY; NOSE CARTILAGE; PRIORITY JOURNAL; TISSUE CULTURE;

EID: 0031785107     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.51.5.282     Document Type: Article

References (41)

1. Kempson G. The mechanical properties of articular cartilage. In: Sokoloff L, ed. The joints and synovial fluid. New York: Academic Press, 1980:177-238.
2. Poole AR. Cartilage in health and disease. In: McCarry DJ, Koopman WJ, eds. Arthritis and allied conditions: a textbook of rheumatology. Philadelphia: Lea and Febiqer, 1993:279-333.
3. Saklatvala J. Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 1986;322:547-9.
4. Saklatvala J, Pilsworth LMC, Sarsfield SJ, et al. Pig catabolin is a form of interleukin I. Cartilage and bone resorb, fibroblasts make prostaglandin and collagonase, and thymocyte proliferation is augmented in response to one protein. Biochem J 1984;224:461-6.
5. Buttle DJ, Bramwell H, Hollander AP. Proteolytic mechanisms of cartilage breakdown - a target for arthritis therapy? J Clin Pathol: Mol Pathol 1995;48:M167-77.
6. Pelletier J-P, Martel-Pelletier J, Mehraban F, et al. Immunological analysis of proteoglycan structural changes in the early stage of experimental osteoarthritic canine cartilage lesions. J Orthop Res 1992;10:511-23.
7. Murphy G, Cockett MI, Ward RV, et al. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem J 1991; 277:277-9.
8. Hughes C, Murphy G, Hardingham TE. Metalloproteinase digestion of cartilage proteoglycan. Pattern of cleavage by stromelysin and susceptibility to collagenase. Biochem J 1991;279:733-9.
9. Bonassar LJ, Frank EH, Murray JC, et al. Changes in cartilage composition and physical properties due to stromelysin degradation. Arthritis Rheum 1945;38:173-83.
10. Bonassar IJ, Jeffries KA, Frank EH, et al. In vivo effects of stromelysin on the composition and physical properties of rabbit articular cartilage in the presence and absence of a synthetic inhibitor. Arthritis Rheum 1995;38:1678-86.
11. MacNaul KL, Chartrain N, Lark M, et al. Discordinate expression of stromelysin, collagenase, and tissue inhibitor of metalloproteinases-1 in rheumatoid synovial fibroblasts. Synergistic effect of interleukin-1 and tumor necrosis factor-α on stromelysin expression. J Biol Chem 1990;265: 17238-45.
12. Manicourt D-H, Fujimoto N, Obata K, et al. Serum levels of collagenase, stromelysin-1, and TIMP-1. Age- and sex-related differences in normal subjects and relationship to the extent of joint involvement and serum levels of antigenic keratan sulfate in patients with osteoarthritis. Arthritis Rheum 1994;37:1774-83.
13. Chubinskaya S, Huch K, Mikecz K, et al. Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1β in human cartilage from knee and ankle joints. Lab Invest 1996;74;232-40.
14. Freije JMP, Diez-Itza I, Balbin M, et al. Molecular cloning and expression of collagenase- 3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994;269:16766-73.
15. Reboul P, Pelletier J-P, Tardif G, et al. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. J Clin Invest 1996;97:2011-19.
16. Knäuper V, Lopez-Otin C, Smith R, et al. Biochemical characterization of human collagenase-3. J Biol Chem 1996; 271:1544-50.
17. Billinghurst RC, Dahlberg L, Ionescu M, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997;99:1534-45.
18. Kozaci LD, Buttle DJ, Hollander AP. Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures. Arthritis Rheum 1997;40:164-74.
19. Mitchell PG, Magna HA, Reeves LM, et al. Cloning, expression and type II collagenolytic activity of matrix metalloproteinase-13 (MMP-13; collagenase-3) from human osteoarthritic cartilage. J Clin Invest 1996;97:761-8.
20. Fosang AJ, Last K, Neame PJ, et al. Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan. Biochem J 1994;304:347-51.
21. Fosang AJ, Last K, Knäuper V, et al. Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett 1996;380:17-20.
22. Buttle DJ, Handley CJ, Ilic MZ, et al. Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metalloproteinases. Evidence for two converging pathways of chondrocyte-mediated proteoglycan degradation. Arthritis Rheum 1993;36:1709-17.
23. Andrews HJ, Plumpton TA, Harper GP, et al. A synthetic peptide metalloproteinase inhibitor, but not Timp, prevents the breakdown of proteoglycan within articular cartilage in vitro. Agents Actions 1992;37:147-54.
24. Nixon JS, Bottomley KMK, Broadhurst MJ, et al. Potent collagenase inhibitors prevent interleukin 1-induced cartilage degradation in vitro. Int J Tissue React 1991;13:237-43.
25. Caputo CB, Sygowski LA, Wolanin DJ, et al. Effect of synthetic metalloprotease inhibitors on cartilage autolysis in vitro. J Pharmacol Exp Ther 1987;240:460-5.
26. Brown CJ, Rahman S, Morton AC, et al. Inhibitors of collagenase but not of gelatinase reduce cartilage explant proteoglycan breakdown despite only low levels of matrix metalloproteinase activity. J Clin Pathol: Mol Pathol 1996;49: M331-9.
27. Davies B, Brown PD, East N, et al. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res 1993;53:2087-91.
28. Patent No. WO96 33165. Derivatives of succinamide and their uses as metalloproteinase inhibitors, 1996.
29. 11C]acetylated collagen. Anal Biochem 1979;99:340-5.
30. Cawston TE, Galloway WA, Mercer E, et al. Purification of rabbit bone inhibitor of collagenase. Biohem J 1981;195: 159-65.
31. Sellers A, Reynolds JJ, Meikle MC. Neutral metalloproteinases of rabbit bone. Separation in latent forms of distinct enzymes that when activated degrade collagen, gelatin and proteoglycans. Biochem J 1979;171:493-6.
32. Buttle DJ, Saklatvala J, Tamai M, et al. Inhibition of interleukin 1-stimulated cartilage proteoglycan degradation by a lipophilic inactivator of cysteine endopeptidases. Biochem J 1992;281:175-7.
33. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986;883: 173-7.
34. Hollander AP, Heathfield TF, Webber C, et al. Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest 1994;93: 1722-32.
35. Stefanovic-Racic M, Stadler J, Georgescu HI, et al. Nitric oxide and energy production in articular chondrocytes. J Cell Physiol 1994;159:274-80.
36. Ellis AJ, Curry VA, Powell EK, et al. The prevention of collagen breakdown in bovine nasal cartilage by TIMP, TIMP-2 and a low molecular weight synthetic inhibitor. Biochem Biophys Res Commun 1994;201:94-101.
37. Yocum SA, Lopresti-Morrow LL, Gabel CA, et al. Bafilomycin A1 inhibits IL-1-stimulated proteoglycan degradation by chondrocytes without affecting stromelysin synthesis. Arch Biochem Biophys 1995;316;827-35.
38. Bottomley KM, Borkakoti N, Bradshaw D, et al. Inhibition of bovine nasal cartilage degradation by selective matrix metalloproteinase inhibitors. Biochem J 1997;323:483-8.
39. Cawston TH, Ellis AJ, Humm G, et al. Interletikin-1 and oncostatin M in combination promote the release of collagen fragments from bovine nasal cartilage in culture. Biochem Biophys Res Commun 1995;215:377-85.
40. Wu J-J, Lark MW, Chun LE, et al. Sites of stromelysin cleavage in collagen types II, IX, X and XI. J Biol Chem 1991;266:5625-8.
41. Suzuki K, Enghild JJ, Morodomi T, et al. Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry 1990;29:10261-70.